Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71,707Revenue $M20,247Net Margin (%)10.8Z-Score3.8
Enterprise Value $M75,205EPS $1.5Operating Margin %13.1F-Score7
P/E(ttm))31.8Cash Flow Per Share $6.7Pre-tax Margin (%)12.7Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %-3.0Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %-19.5Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %10.3ROA % (ttm)5.4Higher Current Ratio y-yN
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)9.8Less Shares Outstanding y-yY
Payout Ratio %79.0Shares Outstanding M1,509ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTMason Hawkins 2014-12-31 Reduce-0.79%$39.99 - $46.37
($43.58)
$ 47.498%Reduce -28.08%8,977,941
ABTGeorge Soros 2014-12-31 Reduce-0.06%$39.99 - $46.37
($43.62)
$ 47.498%Reduce -24.46%602,181
ABTMario Gabelli 2014-12-31 Reduce-0.01%$39.99 - $46.37
($43.58)
$ 47.498%Reduce -33.96%65,337
ABTKen Fisher 2014-12-31 Add$39.99 - $46.37
($43.58)
$ 47.498%Add 22.80%13,828
ABTMason Hawkins 2014-09-30 Reduce-0.26%$41.05 - $43.69
($42.33)
$ 47.4911%Reduce -8.80%12,483,566
ABTMario Gabelli 2014-09-30 Reduce-0.01%$41.05 - $43.69
($42.33)
$ 47.4911%Reduce -38.44%98,937
ABTKen Fisher 2014-09-30 Reduce$41.05 - $43.69
($42.33)
$ 47.4911%Reduce -37.53%11,261
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 47.4917%New holding1,665,688
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 47.4917%Reduce -23.73%932,181
ABTKen Fisher 2014-06-30 Add$37.02 - $41
($39.24)
$ 47.4917%Add 106.12%18,027
ABTRichard Pzena 2014-03-31 Add0.11%$35.85 - $40.12
($38.5)
$ 47.4919%Add 7.90%6,934,282
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 47.4919%Add 25.97%1,222,181
ABTRobert Olstein 2013-12-31 Add0.19%$33.01 - $38.71
($36.89)
$ 47.4922%Add 23.45%179,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 47.4922%Add 110.21%197,183
ABTRichard Pzena 2013-09-30 Add0.46%$32.93 - $36.88
($35.12)
$ 47.4926%Add 49.22%6,449,283
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 47.4926%Reduce -4.79%13,727,856
ABTKen Fisher 2013-09-30 Reduce$32.93 - $36.88
($35.12)
$ 47.4926%Reduce -21.02%8,439
ABTVanguard Health Care Fund 2013-06-30 Reduce-0.24%$34.88 - $38.56
($36.68)
$ 47.4923%Reduce -18.79%7,591,400
ABTRobert Olstein 2013-03-31 Buy 0.8%$31.34 - $35.32
($33.84)
$ 47.4929%New holding129,000
ABTRichard Pzena 2013-03-31 Add0.62%$31.34 - $35.32
($33.84)
$ 47.4929%Add 127.45%4,434,735
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Contreras JaimeSenior Vice President 2015-03-31Sell228$46.434.37view
White J. ScottSenior Vice President 2015-03-26Sell12,483$46.683.81view
Warmuth Michael JExecutive Vice President 2015-03-10Sell13,500$46.414.42view
Pavee Jean-YvesSenior Vice President 2015-03-02Sell652$47.482.06view
Contreras JaimeSenior Vice President 2015-03-02Sell9,209$47.342.37view
Contreras JaimeSenior Vice President 2015-02-18Sell423$46.264.76view
Pavee Jean-YvesSenior Vice President 2015-02-17Sell621$46.414.42view
ALLEN HUBERT LExecutive Vice President 2015-02-17Sell172$46.384.48view
Simhambhatla Murthy VSenior Vice President 2015-02-17Sell172$46.414.42view
CAPEK JOHN MExecutive Vice President 2015-02-04Sell34,292$45.666.13view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    How Much Money Will You Need To Retire? Mar 31 2015 
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    AbbVie’s Q4 Reflects Its Tremendous Growth Potential Going Forward Feb 04 2015 
    What Could Be The Major Highlights In AbbVie’s Upcoming Earnings Call? Jan 29 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Diamond Hill Adds Two Companies to Portfolio in Third Quarter Dec 11 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Top 7 Dividend Aristocrats: The Best of The Best Dec 10 2014 
    6 Stocks Giving Investors Potential Dividend Hikes In December Dec 04 2014 


    More From Other Websites
    DepoMed Set To Grow On 'Transformative' Nucynta Deal Apr 23 2015
    Dealpolitik: Three Ways to Look at the Three-Way Pharma Scrum Apr 23 2015
    Earnings for US Multinationals Beat Estimates Despite Currency War Apr 23 2015
    Abbvie's CEO Gonzalez: We're Now In Pharma's 'Top Tier' Apr 23 2015
    Company News for April 23, 2015 - Corporate Summary Apr 23 2015
    Mylan readies its poison pill defences Apr 22 2015
    Abbott Laboratories (ABT) Stock Gained Today on Strong Earnings Beat Apr 22 2015
    Abbott posts profit beat Apr 22 2015
    Earnings Beat Propels Abbott Laboratories To New All-Time High Apr 22 2015
    Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog Apr 22 2015
    Mylan Deal Is Abbott’s Gain as Drugmaker’s Stake Grows and Grows Apr 22 2015
    Abbott Laboratories (ABT) Earnings Report: Q1 2015 Conference Call Transcript Apr 22 2015
    Abbott says its payoff from Mylan deal surged Apr 22 2015
    Abbott says payoff from Mylan deal surges, as Mylan shares leap Apr 22 2015
    St. Jude, Abbott Labs Beat Q1 Expectations Apr 22 2015
    Abbott Labs (ABT) Beats On Earnings in Q1 - Tale of the Tape Apr 22 2015
    Abbott Labs Reports Better-Than-Expected Profit Apr 22 2015
    Abbott profit beats expectations, sales of branded generics jump Apr 22 2015
    Abbott Profit Beats Estimates as Emerging Market Sales Rise Apr 22 2015
    Abbott Laboratories Earnings Call scheduled for 9:00 am ET today Apr 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK